Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2017-07-25, XBRL Interactive Financials
Original SEC Filing: Click here
Webplus: CO/20170725/20-F/1/000.htm SEC Original: a17-10321_120f.htm
FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1
Webplus: CO/20170725/20-F/2_EX-8.1/000.htm SEC Original: a17-10321_1ex8d1.htm
List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Peoples Republic of China Zhejiang Lukou Biotechnology Co., Ltd. Peoples Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem
Webplus: CO/20170725/20-F/3_EX-12.1/000.htm SEC Original: a17-10321_1ex12d1.htm
Certification I, Ting Zheng, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 25, 2017 Ting Zheng Chief Executive Officer EX-12.1 3 a17-10321_1ex12d1.htm EX-12.1
Webplus: CO/20170725/20-F/4_EX-12.2/000.htm SEC Original: a17-10321_1ex12d2.htm
Certification I, Albert Chen, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 25, 2017 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-12.2 4 a17-10321_1ex12d2.htm EX-12.2
Webplus: CO/20170725/20-F/5_EX-13.1/000.htm SEC Original: a17-10321_1ex13d1.htm
Certification CHINA CORD BLOOD CORPORATION July 25, 2017 Ting Zheng Chief Executive Officer July 25, 2017 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a17-10321_1ex13d1.htm EX-13.1
Webplus: CO/20170725/20-F/6_EX-15.1/000.htm SEC Original: a17-10321_1ex15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-213730 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated statements of comprehensive income, changes in equity, and cash flows of China Cord
Webplus: CO/20170725/20-F/7_EX-15.2/000.htm SEC Original: a17-10321_1ex15d2.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-213730 on Form F-3 of China Cord Blood Corporation of our reports dated July 25, 2017, with respect to the consolidated balance sheets of China Cord Blood Corporation and subsidiaries as of March 31,
Webplus: CO/20170725/20-F/8_EX-15.3/000.htm SEC Original: a17-10321_1ex15d3.htm
China Cord Blood Corporation 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Madams and Sirs, Yours faithfully, Zhong Lun Law Firm EX-15.3 8 a17-10321_1ex15d3.htm EX-15.3
Company Info:
Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2017-07-25, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.